VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U5316AA: VAERS reports

21 VAERS reports list lot U5316AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2016-03-20 and 2019-03-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
33%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1425%
Injection-site / Local reaction1425%
Musculoskeletal814%
Cardiac / Cardiovascular611%
Gastrointestinal611%
Neurological59%
Allergic / Anaphylactic35%
Respiratory12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
Texas4
Florida2
Virginia1
Georgia1
North Carolina1
Oregon1
Iowa1
Michigan1
Louisiana1
Idaho1
New York1

Reports by month received

2016-031
2016-046
2016-051
2016-062
2016-072
2016-082
2016-091
2016-102
2016-121
2017-101
2018-071
2019-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.